Skip to main content
Log in

Adverse drug reactions: more than a warning!

  • Editorial
  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rikken F, Vos R. How adverse drug reactions can play a role in innovative drug research. Similarities in adverse drug reaction profiles of captopril and penicillamine. Pharm World Sci 1995;17(6):195–200.

    PubMed  Google Scholar 

  2. Kurt U, Ozkardes H, Altug U, Germiyanoglu C, Gurdal M, Erol D. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. J Urol 1994;152:407–9.

    PubMed  Google Scholar 

  3. Gansevoort RT, de Zeeuw R, de Jong PE. Effects of ACE inhibitors and Ang II antagonism. Is the antiproteinuric effect of ACE inhibition mediated by interference in the reninangiotensin system? Kidney Int 1994;45:861–7.

    PubMed  Google Scholar 

  4. Herings RMC, Stricker BHC, Leufkens HGM, Bakker A, Sturmans F, Urquhart J. Public health and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in the Netherlands. Pharm World Sci 1993;15(5):212–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Jong-van den Berg, L. Adverse drug reactions: more than a warning!. Pharm World Sci 17, 177 (1995). https://doi.org/10.1007/BF01870607

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01870607

Keywords

Navigation